Revenue: The sum of all revenue fields included for a company's operating activities.
Arrowhead Pharmaceuticals, Inc. (ARWR) had Revenue of $264.03M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
|
Revenue |
$264.03M |
$30.81M |
|
-- |
|
$264.03M |
|
$223.22M |
|
$40.81M |
|
$-12.54M |
|
$28.27M |
|
$28.27M |
|
$28.24M |
|
$28.24M |
|
$28.24M |
|
$28.24M |
|
$40.81M |
|
$47.20M |
|
137.04M |
|
140.71M |
|
$0.22 |
|
$0.22 |
|
| Balance Sheet Financials | |
$1.17B |
|
$378.58M |
|
$429.79M |
|
$1.60B |
|
$347.43M |
|
$163.11M |
|
$694.06M |
|
$1.04B |
|
$562.70M |
|
$556.26M |
|
$562.70M |
|
137.39M |
|
| Cash Flow Statement Financials | |
$13.48M |
|
$-23.74M |
|
$-14.75M |
|
$226.55M |
|
$201.64M |
|
$-24.91M |
|
$19.37M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.38 |
|
-- |
|
-- |
|
0.22 |
|
0.36 |
|
100.00% |
|
15.46% |
|
15.46% |
|
-- |
|
10.71% |
|
11.67% |
|
$11.33M |
|
-- |
|
-- |
|
-- |
|
0.16 |
|
-- |
|
1.21 |
|
74.61 |
|
5.02% |
|
5.08% |
|
1.76% |
|
3.89% |
|
$4.10 |
|
$0.08 |
|
$0.10 |
|